Katharina Möller

graph of relations

Publications

  1. 2023
  2. BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration

    Bady, E., Moeller, K., Mandelkow, T., Raedler, J. B., Yang, C., Ebner, J., Lurati, M. C. J., Simon, R., Vettorazzi, E., Büscheck, F., Luebke, A. M., Dum, D., Menz, A., Sauter, G., Hoeflmayer, D., Weidemann, S., Fraune, C., Uhlig, R., Bernreuther, C., Jacobsen, F., Clauditz, T. S., Wilczak, W., Burandt, E., Steurer, S., Minner, S., Lennartz, M. & Blessin, N. C., 01.06.2023, In: MOL CANCER RES. 21, 6, p. 605-613 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors

    Dum, D., Kromm, D., Lennartz, M., De Wispelaere, N., Büscheck, F., Luebke, A. M., Burandt, E., Menz, A., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Lebok, P., Sauter, G., Simon, R., Uhlig, R., Wilczak, W., Minner, S., Krech, R., Bernreuther, C., Marx, A., Steurer, S., Jacobsen, F., Clauditz, T. & Krech, T., 01.04.2023, In: ARCH PATHOL LAB MED. 147, 4, p. 451-464 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas

    Uhlig, R., Bröker, N., Weidemann, S., Gorbokon, N., Menz, A., Büscheck, F., Luebke, A. M., Putri, D., Kluth, M., Hube-Magg, C., Hinsch, A., Lennartz, M., Reiswich, V., Höflmayer, D., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Sauter, G., Minner, S., Steurer, S., Burandt, E., Krech, R., Dum, D., Marx, A., Simon, R., Krech, T., Clauditz, T. S. & Jacobsen, F., 2023, In: PLOS ONE. 18, 6, p. e0287528

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors

    Reiswich, V., Schmidt, C. E., Lennartz, M., Höflmayer, D., Hube-Magg, C., Weidemann, S., Fraune, C., Büscheck, F., Möller, K., Bernreuther, C., Simon, R., Clauditz, T. S., Blessin, N. C., Bady, E., Sauter, G., Uhlig, R., Steurer, S., Minner, S., Burandt, E., Dum, D., Marx, A. H., Krech, T., Lebok, P., Hinsch, A. & Jacobsen, F., 2023, In: PATHOBIOLOGY. 90, 4, p. 219-232 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples

    Möller, K., Knöll, M., Bady, E., Schmerder, M. J., Rico, S. D., Kluth, M., Hube-Magg, C., Blessin, N. C., Mandelkow, T., Lennartz, M., Menz, A., Luebke, A. M., Höflmayer, D., Fraune, C., Bernreuther, C., Lebok, P., Uhlig, R., Contreras, H., Weidemann, S., Gorbokon, N., Jacobsen, F., Clauditz, T. S., Steurer, S., Burandt, E., Minner, S., Sauter, G., Simon, R., Marx, A. H. & Krech, T., 2023, In: CANCER BIOMARK. 36, 2, p. 177-191 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2022
  8. Synaptophysin and chromogranin A expression analysis in human tumors

    Uhlig, R., Dum, D., Gorbokon, N., Menz, A., Büscheck, F., Luebke, A. M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Weidemann, S., Lennartz, M., Jacobsen, F., Clauditz, T. S., Sauter, G., Wilczak, W., Steurer, S., Burandt, E., Krech, R., Krech, T., Marx, A. H., Simon, R. & Minner, S., 15.09.2022, In: MOL CELL ENDOCRINOL. 555, 111726.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma

    Dwertmann Rico, S., Büscheck, F., Dum, D., Luebke, A. M., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Perez, D., Izbicki, J. R., Neipp, M., Mofid, H., Daniels, T., Isbert, C., Fraune, C., Möller, K., Menz, A., Bernreuther, C., Lebok, P., Clauditz, T., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Burandt, E., Marx, A. & Krech, T., 29.06.2022, In: INT J IMMUNOPATH PH. 36, 3946320221106504.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence

    Dum, D., Henke, T. L. C., Mandelkow, T., Yang, C., Bady, E., Raedler, J. B., Simon, R., Sauter, G., Lennartz, M., Büscheck, F., Luebke, A. M., Menz, A., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Lebok, P., Uhlig, R., Bernreuther, C., Jacobsen, F., Clauditz, T. S., Wilczak, W., Minner, S., Burandt, E., Steurer, S. & Blessin, N. C., 06.2022, In: LAB INVEST. 102, 6, p. 650-657 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas

    Uhlig, R., Contreras, H., Weidemann, S., Gorbokon, N., Menz, A., Büscheck, F., Luebke, A. M., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Sauter, G., Wilczak, W., Izbicki, J., Perez, D., Schrader, J., Steurer, S., Burandt, E., Krech, R., Dum, D., Krech, T., Marx, A., Simon, R., Minner, S., Jacobsen, F. & Clauditz, T. S., 01.01.2022, In: AM J SURG PATHOL. 46, 1, p. 97-104 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. High prevalence of p16 staining in malignant tumors

    De Wispelaere, N., Rico, S. D., Bauer, M., Luebke, A. M., Kluth, M., Büscheck, F., Hube-Magg, C., Höflmayer, D., Gorbokon, N., Weidemann, S., Möller, K., Fraune, C., Bernreuther, C., Simon, R., Kähler, C., Menz, A., Hinsch, A., Jacobsen, F., Lebok, P., Clauditz, T., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Burandt, E., Krech, R., Dum, D., Krech, T., Marx, A. & Minner, S., 2022, In: PLOS ONE. 17, 7, e0262877.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. 2021
  14. Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours

    Meiners, J., Jansen, K., Gorbokon, N., Büscheck, F., Luebke, A. M., Kluth, M., Hube-Magg, C., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Menz, A., Jacobsen, F., Clauditz, T., Sauter, G., Uhlig, R., Wilczak, W., Izbicki, J., Perez, D., Minner, S., Burandt, E., Krech, T., Marx, A., Simon, R. & Steurer, S., 03.12.2021, In: BIOMEDICINES. 9, 12, 1831.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples

    Jansen, K., Farahi, N., Büscheck, F., Lennartz, M., Luebke, A. M., Burandt, E., Menz, A., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Lebok, P., Sauter, G., Simon, R., Uhlig, R., Wilczak, W., Jacobsen, F., Minner, S., Krech, R., Clauditz, T., Bernreuther, C., Dum, D., Krech, T., Marx, A. & Steurer, S., 12.2021, In: PATHOL RES PRACT. 228, 153663.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer

    Möller, K., Fraune, C., Blessin, N. C., Lennartz, M., Kluth, M., Hube-Magg, C., Lindhorst, L., Dahlem, R., Fisch, M., Eichenauer, T., Riechardt, S., Simon, R., Sauter, G., Büscheck, F., Höppner, W., Matthies, C., Doh, O., Krech, T., Marx, A. H., Zecha, H., Rink, M., Steurer, S. & Clauditz, T. S., 12.2021, In: INT UROL NEPHROL. 53, 12, p. 2493-2503 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin

    Steurer, S., Schneider, J., Büscheck, F., Luebke, A. M., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Menz, A., Bernreuther, C., Lebok, P., Sauter, G., Simon, R., Jacobsen, F., Uhlig, R., Wilczak, W., Minner, S., Burandt, E., Krech, R. H., Dum, D., Krech, T., Marx, A. H. & Clauditz, T. S., 10.2021, In: ANN DIAGN PATHOL. 54, p. 151793

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples

    Rico, S. D., Mahnken, M., Büscheck, F., Dum, D., Luebke, A. M., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Möller-Koop, C., Fraune, C., Möller, K., Menz, A., Bernreuther, C., Jacobsen, F., Lebok, P., Clauditz, T. S., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Minner, S., Burandt, E., Krech, T. & Marx, A. H., 23.09.2021, In: TECHNOL CANCER RES T. 20, 15330338211043328.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer

    Möller, K., Blessin, N. C., Höflmayer, D., Büscheck, F., Luebke, A. M., Kluth, M., Hube-Magg, C., Zalewski, K., Hinsch, A., Neipp, M., Mofid, H., Lárusson, H., Daniels, T., Isbert, C., Coerper, S., Ditterich, D., Rupprecht, H., Goetz, A., Bernreuther, C., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Minner, S., Burandt, E., Krech, T., Perez, D., Izbicki, J. R., Clauditz, T. S. & Marx, A. H., 09.2021, In: ACTA ONCOL. 60, 9, p. 1210-1217 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers

    Blessin, N. C., Li, W., Mandelkow, T., Jansen, H. L., Yang, C., Raedler, J. B., Simon, R., Büscheck, F., Dum, D., Luebke, A. M., Hinsch, A., Möller, K., Menz, A., Bernreuther, C., Lebok, P., Clauditz, T., Sauter, G., Marx, A., Uhlig, R., Wilczak, W., Minner, S., Krech, T., Fraune, C., Höflmayer, D., Burandt, E. & Steurer, S., 08.2021, In: CELL ONCOL. 44, 4, p. 793-803 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors

    Burandt, E., Lübbersmeyer, F., Gorbokon, N., Büscheck, F., Luebke, A. M., Menz, A., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Jacobsen, F., Lebok, P., Clauditz, T. S., Sauter, G., Simon, R., Uhlig, R., Wilczak, W., Steurer, S., Minner, S., Krech, R., Dum, D., Krech, T., Marx, A. H. & Bernreuther, C., 05.06.2021, In: BIOMARK RES. 9, 1, p. 44

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Prevalence of proliferating CD8+ cells in normal lymphatic tissues, inflammation and cancer

    Blessin, N. C., Abu-Hashem, R., Mandelkow, T., Li, W., Simon, R., Hube-Magg, C., Möller-Koop, C., Witt, M., Schmidt, A., Büscheck, F., Fraune, C., Luebke, A. M., Möller, K., Jacobsen, F., Lutz, F., Lennartz, M., Steurer, S., Sauter, G., Höflmayer, D., Tsourlakis, M. C., Hinsch, A., Burandt, E., Wilczak, W., Minner, S. & Clauditz, T. S., 03.06.2021, In: AGING-US. 13, 11, p. 14590-14603 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer

    Rico, S. D., Höflmayer, D., Büscheck, F., Dum, D., Luebke, A. M., Kluth, M., Hube-Magg, C., Hinsch, A., Möller-Koop, C., Perez, D., Izbicki, J. R., Neipp, M., Mofid, H., Lárusson, H., Daniels, T., Isbert, C., Coerper, S., Ditterich, D., Rupprecht, H., Goetz, A., Fraune, C., Möller, K., Menz, A., Bernreuther, C., Clauditz, T. S., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Lebok, P., Burandt, E., Krech, T. & Marx, A. H., 06.2021, In: MED MOL MORPHOL. 54, 2, p. 156-165 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors

    Weidemann, S., Gagelmann, P., Gorbokon, N., Lennartz, M., Menz, A., Luebke, A. M., Kluth, M., Hube-Magg, C., Blessin, N. C., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Clauditz, T. S., Jacobsen, F., Izbicki, J. R., Jansen, K., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Minner, S., Burandt, E., Krech, R. H., Dum, D., Krech, T., Marx, A. H. & Simon, R., 07.04.2021, In: BIOMEDICINES. 9, 4, 397.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer

    Höflmayer, D., Fraune, C., Hube-Magg, C., Simon, R., Schroeder, C., Büscheck, F., Möller, K., Dum, D., Weidemann, S., Wittmer, C., Schlomm, T., Huland, H., Heinzer, H., Graefen, M., Haese, A., Sauter, G., Burandt, E., Clauditz, T. S., Steurer, S., Minner, S., Wilczak, W. & Polonski, A., 01.04.2021, In: APPL IMMUNOHISTO M M. 29, 4, p. e29-e38

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors

    Menz, A., Weitbrecht, T., Gorbokon, N., Büscheck, F., Luebke, A. M., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Clauditz, T., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Minner, S., Burandt, E., Krech, R., Dum, D., Krech, T., Marx, A. & Simon, R., 15.02.2021, In: MOL MED. 27, 1, p. 16

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer

    Möller, K., Kluth, M., Ahmed, M., Burkhardt, L., Möller-Koop, C., Büscheck, F., Weidemann, S., Tsourlakis, M-C., Minner, S., Heinzer, H., Huland, H., Graefen, M., Sauter, G., Schlomm, T., Dum, D. & Simon, R., 01.02.2021, In: INT J CANCER. 148, 3, p. 748-758 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma

    Eichenauer, T., Simmendinger, L., Fraune, C., Mandelkow, T., Blessin, N. C., Kluth, M., Hube-Magg, C., Möller, K., Clauditz, T., Weidemann, S., Dahlem, R., Fisch, M., Riechardt, S., Simon, R., Sauter, G., Büscheck, F. & Rink, M., 02.2021, In: WORLD J UROL. 39, 2, p. 481-490 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors

    Steurer, S., Riemann, C., Büscheck, F., Luebke, A. M., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Menz, A., Fisch, M., Rink, M., Bernreuther, C., Lebok, P., Clauditz, T. S., Sauter, G., Uhlig, R., Wilczak, W., Dum, D., Simon, R., Minner, S., Burandt, E., Krech, R., Krech, T. & Marx, A. H., 25.01.2021, In: BIOMARK RES. 9, 1, 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness

    Jansen, K., Büscheck, F., Moeller, K., Kluth, M., Hube-Magg, C., Blessin, N. C., Perez, D., Izbicki, J., Neipp, M., Mofid, H., Daniels, T., Nahrstedt, U., Fraune, C., Jacobsen, F., Bernreuther, C., Lebok, P., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Burandt, E., Marx, A., Krech, T. & Clauditz, T., 2021, In: PEERJ. 9, e11905.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Napsin A Expression in Human Tumors and Normal Tissues

    Weidemann, S., Böhle, J. L., Contreras, H., Luebke, A. M., Kluth, M., Büscheck, F., Hube-Magg, C., Höflmayer, D., Möller, K., Fraune, C., Bernreuther, C., Rink, M., Simon, R., Menz, A., Hinsch, A., Lebok, P., Clauditz, T., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Burandt, E., Krech, R., Dum, D., Krech, T., Marx, A. & Minner, S., 2021, In: PATHOL ONCOL RES. 27, p. 613099

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. 2020
  33. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

    Freytag, M., Kluth, M., Bady, E., Hube-Magg, C., Makrypidi-Fraune, G., Heinzer, H., Höflmayer, D., Weidemann, S., Uhlig, R., Huland, H., Graefen, M., Bernreuther, C., Wittmer, C., Tsourlakis, M. C., Minner, S., Dum, D., Hinsch, A., Luebke, A. M., Simon, R., Sauter, G., Schlomm, T. & Möller, K., 18.12.2020, In: BMC CANCER. 20, 1, p. 1220

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

    Möller, K., Wecker, A. L., Höflmayer, D., Fraune, C., Makrypidi-Fraune, G., Hube-Magg, C., Kluth, M., Steurer, S., Clauditz, T. S., Wilczak, W., Simon, R., Sauter, G., Huland, H., Heinzer, H., Haese, A., Schlomm, T., Weidemann, S., Luebke, A. M., Minner, S., Bernreuther, C., Bonk, S. & Marx, A., 11.2020, In: VIRCHOWS ARCH. 477, 5, p. 625-636 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. High B7-H3 expression is linked to increased risk of prostate cancer progression

    Bonk, S., Tasdelen, P., Kluth, M., Hube-Magg, C., Makrypidi-Fraune, G., Möller, K., Höflmayer, D., Dwertmann Rico, S., Büscheck, F., Minner, S., Heinzer, H., Graefen, M., Hinsch, A., Luebke, A. M., Dum, D., Uhlig, R., Schlomm, T., Sauter, G., Simon, R. & Weidemann, S. A., 10.2020, In: PATHOL INT. 70, 10, p. 733-742 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

    Bernreuther, C., Daghigh, F., Möller, K., Hube-Magg, C., Lennartz, M., Lutz, F., Rico, S. D., Fraune, C., Dum, D., Luebke, A. M., Eichenauer, T., Möller-Koop, C., Schlomm, T., Wittmer, C., Huland, H., Heinzer, H., Graefen, M., Haese, A., Burandt, E., Tsourlakis, M. C., Clauditz, T. S., Höflmayer, D., Izbicki, J. R., Simon, R., Sauter, G., Minner, S., Steurer, S. & Meiners, J., 10.2020, In: PATHOL ONCOL RES. 26, 4, p. 2709-2722 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer

    Bonk, S., Kluth, M., Jansen, K., Hube-Magg, C., Makrypidi-Fraune, G., Höflmayer, D., Weidemann, S., Möller, K., Uhlig, R., Büscheck, F., Luebke, A. M., Burandt, E., Clauditz, T. S., Steurer, S., Schlomm, T., Huland, H., Heinzer, H., Sauter, G., Simon, R. & Dum, D., 09.2020, In: PROSTATE. 80, 13, p. 1097-1107 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

    Luebke, A. M., Ricken, W., Kluth, M., Hube-Magg, C., Schroeder, C., Büscheck, F., Möller, K., Dum, D., Höflmayer, D., Weidemann, S., Fraune, C., Hinsch, A., Wittmer, C., Schlomm, T., Huland, H., Heinzer, H., Graefen, M., Haese, A., Minner, S., Simon, R., Sauter, G., Wilczak, W. & Meiners, J., 15.07.2020, In: INT J CANCER. 147, 2, p. 575-583 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

    Marx, A., Schumann, A., Höflmayer, D., Bady, E., Hube-Magg, C., Möller, K., Tsourlakis, M. C., Steurer, S., Büscheck, F., Eichenauer, T., Clauditz, T. S., Graefen, M., Simon, R., Sauter, G., Izbicki, J. R., Huland, H., Heinzer, H., Haese, A., Schlomm, T., Bernreuther, C., Lebok, P. & Polonski, A., 02.06.2020, In: SCI REP-UK. 10, 1, p. 8916

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

    Eichenauer, T., Federlein, F., Möller, K., Chirico, V., Kind, S., Lennartz, M., Lutz, F., Hube-Magg, C., Höflmayer, D., Fisch, M., Huland, H., Heinzer, H., Graefen, M., Haese, A., Schroeder, C., Lebok, P., Minner, S., Simon, R., Sauter, G., Schlomm, T., Wilczak, W., Steurer, S. & Luebke, A. M., 06.2020, In: PATHOLOGY. 52, 4, p. 421-430 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

    Blessin, N. C., Spriestersbach, P., Li, W., Mandelkow, T., Dum, D., Simon, R., Hube-Magg, C., Lutz, F., Viehweger, F., Lennartz, M., Fraune, C., Nickelsen, V., Fehrle, W., Göbel, C., Weidemann, S., Clauditz, T., Lebok, P., Möller, K., Steurer, S., Izbicki, J. R., Sauter, G., Minner, S., Jacobsen, F., Luebke, A. M., Büscheck, F., Höflmayer, D., Wilczak, W., Burandt, E. & Hinsch, A., 06.2020, In: CELL ONCOL. 43, 3, p. 421-430 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. High homogeneity of mismatch repair deficiency in advanced prostate cancer

    Fraune, C., Simon, R., Höflmayer, D., Möller, K., Dum, D., Büscheck, F., Hube-Magg, C., Makrypidi-Fraune, G., Kluth, M., Hinsch, A., Burandt, E., Clauditz, T. S., Wilczak, W., Sauter, G. & Steurer, S., 05.2020, In: VIRCHOWS ARCH. 476, 5, p. 745-752 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

    Fraune, C., Harms, L., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Simon, R., Möller, K., Luebke, A. M., Möller-Koop, C., Steurer, S., Hube-Magg, C., Sauter, G., Weidemann, S., Lebok, P., Dum, D., Kind, S., Minner, S., Izbicki, J. R., Schlomm, T., Huland, H., Heinzer, H., Burandt, E., Haese, A., Graefen, M. & Schroeder, C., 06.03.2020, In: MOL MED. 26, 1, p. 24

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. High RSF1 protein expression is an independent prognostic feature in prostate cancer

    Höflmayer, D., Hamuda, M., Schroeder, C., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Weidemann, S., Möller, K., Izbicki, J. R., Jacobsen, F., Mandelkow, T., Blessin, N. C., Lutz, F., Viehweger, F., Sauter, G., Burandt, E., Lebok, P., Lennartz, M., Fraune, C., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Büscheck, F., 03.2020, In: ACTA ONCOL. 59, 3, p. 268-273 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

    Eichenauer, T., Bannenberg, D. C., Kluth, M., Wittmer, C., Büscheck, F., Möller, K., Dum, D., Fraune, C., Hube-Magg, C., Möller-Koop, C., Dahlem, R., Fisch, M., Rink, M., Riechardt, S., Tsourlakis, M. C., Bernreuther, C., Minner, S., Simon, R., Sauter, G., Wilczak, W. & Clauditz, T. S., 02.2020, In: UROL ONCOL-SEMIN ORI. 38, 2, p. 43.e13-43.e20

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

    Büscheck, F., Sulimankhil, M., Melling, N., Höflmayer, D., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Weidemann, S., Izbicki, J. R., Jacobsen, F., Mandelkow, T., Blessin, N. C., Möller-Koop, C., Lutz, F., Viehweger, F., Möller, K., Sauter, G., Lennartz, M., Burandt, E., Lebok, P., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Fraune, C., 02.2020, In: CANCER MED-US. 9, 4, p. 1409-1418 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence

    Kind, S., Kluth, M., Hube-Magg, C., Möller, K., Makrypidi-Fraune, G., Lutz, F., Lennartz, M., Rico, S. D., Schlomm, T., Heinzer, H., Höflmayer, D., Weidemann, S., Uhlig, R., Huland, H., Graefen, M., Bernreuther, C., Tsourlakis, M. C., Minner, S., Dum, D., Hinsch, A., Lübke, A. M., Simon, R., Sauter, G., Marx, A. & Polonski, A., 2020, In: BIOMED RES INT . 2020, p. 5845374

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next